Abstract
To the Editor.— Drs Ballard and Marcus (136:316-319, 1976) reported on impaired platelet aggregation in response to adenosine diphosphate (ADP) in 12 of 24 patients with Laennec cirrhosis. They found no correlation between this abnormality and other tests of hemostasis, like fibrinogen-fibrin split product levels. We studied hemostasis in nine patients with biopsy-proven liver cirrhosis (seven had Laennec, one had postnecrotic, and one had cryptogenic cirrhosis). In five patients, the spleen was enlarged, as judged by isotope scanning. Results of blood coagulation tests showed no great disturbances, except for the invariably prolonged thrombin time. Platelet aggregation in response to ADP, ristocetin, and collagen was studied with an aggregometer with a light-transmission recording technique. Adenosine diphosphate was used in a dilution series with a final concentration of up to 1 μg/ml of platelet-rich plasma (PRP); ristocetin was in a final concentration of 1.2 mg/ ml, and collagen was in a final
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
